<DOC>
	<DOCNO>NCT00928135</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) lung disease characterize chronic bacterial colonization recurrent infection airway . Lowering airway surface liquid ( ASL ) salt concentration show increase activity salt sensitive antimicrobial peptide . Xylitol 5-carbon sugar lower ASL salt concentration , thus enhance innate immunity . In study , investigator propose test safety tolerability aerosolize xylitol use daily 2 week subject cystic fibrosis . In pilot , 2-week study , 60 subject cystic fibrosis FEV1 ( Forced expiratory volume 1 second ) &gt; 30 % predict randomized receive aerosolize 7 % hypertonic saline ( 5 ml ) 15 % xylitol , ( 5 ml ) twice day 14 day . The primary outcome safety assess FEV1 change baseline , adverse event respiratory symptom score . Outcomes trend efficacy include density colonization sputum , time next exacerbation , sputum cytokine revise CF quality life questionnaire .</brief_summary>
	<brief_title>Aerosolized Hypertonic Xylitol Versus Hypertonic Saline Cystic Fibrosis ( CF ) Subjects</brief_title>
	<detailed_description>Cystic fibrosis ( CF ) lung disease characterize chronic bacterial colonization recurrent infection airway . Disruption cystic fibrosis transmembrane conductance regulator chloride channel subject CF result alter fluid electrolyte transport across airway epithelium thereby initiating infection . These infection eventually destroy lung contribute significant morbidity mortality patient CF . It well know antibacterial activity innate immune mediator lysozyme beta defensins human airway surface liquid ( ASL ) salt-sensitive ; increase salt concentration inhibit activity . Conversely , activity increase low ionic strength . Lowering ASL salt concentration increase ASL volume might therefore potentiate innate immunity therefore decrease prevent airway infection subject CF . Xylitol , five-carbon sugar low transepithelial permeability , poorly metabolize bacteria low salt concentration cystic fibrosis ( CF ) non-CF epithelia vitro . Xylitol artificial sweetener successfully use chew gums prevent dental caries ; use oral sugar substitute without significant adverse effect . It also show decrease incidence acute otitis medium 20-40 % ; nasal application normal human subject find decrease colonization coagulase negative staphylococcus . We find aerosolize iso-osmolar xylitol safe mouse , healthy volunteer stable subject CF administer single day . In recent study , observe single dos 10 % follow 15 % xylitol well tolerate subject cystic fibrosis stable . In pilot study propose test hypothesis aerosolize hypertonic xylitol give daily 2 week , safe well tolerate potentially low density colonization subject CF compare hypertonic saline . We choose hypertonic concentration xylitol comparable part hypertonic saline offer routine treatment hospitalize patient CF exacerbation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Subjects CF ( medical record evidence CFTR ( Cystic fibrosis transmembrane conductance regulator ) mutation sweat chloride test nasal voltage difference , 1 clinical finding CF ) , Age 12 great FEV1 &gt; 30 % predict ( within last 14 day oxygen saturation &gt; 90 % FiO2 ( fraction inspire oxygen ) â‰¤ 50 % , Admitted exacerbation , Use effective contraception woman , Able provide write informed consent . Pregnancy , History asthma base methacholine challenge bronchial hyperresponsiveness PFTS ( Pulmonary Function Test ) , Hemoptysis 60 mL within last 30 day , Use investigational study drug within last 30 day , Initiation hypertonic saline within last 30 day , A serum creatinine 2 mg/dl Active malignancy last year Antibiotics CF exacerbation outpatient last 2 week B cepacia colonization Waiting list lung transplant Lack FEV1 data last 14 day Previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>